Unite de Fabrication de Medicaments SA · UMED.TN

Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has laboratories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers. The Company's product portfolio comprises Ophthalmology Otorhinolaryngologicals (OPHTA ORL) like Alzor, Atropine Unimed and Benzosept, among others; liquid injections, such as Bupicaine, Furoxem, Doperan and Ketomed, among others; powders for injections, such as Amoxil, Ampicil and Cefaxone, among others; Otorhinolaryngologicals (ORL) like Ofloxacine; and infusion solutions, such as Glucose 5% and Osmomed 5%, among others. Its durable business profile is based on manufacturing, registering and distributing medicines or healthcare products for domestic and third-party customers. Demand is supported by healthcare needs, hospital and pharmacy channels, product quality, regulatory approvals and the ability to manage specialized production, procurement and compliance requirements.